• 1. Synthesis of N-cyano-substituted sulfilimine and sulfoximine derivatives of S0859 and their biological evaluation as sodium bicarbonate co-transport inhibitors
  Anne-Dorothee Steinkamp,Nico Seling,Soojung Lee,Ebbe Boedtkjer,Carsten Bolm Med. Chem. Commun. 2015 6 2163
• 2. Immobilized boronic acid for Suzuki–Miyaura coupling: application to the generation of pharmacologically relevant molecules
  M. Martinez-Amezaga,C. M. L. Delpiccolo,E. G. Mata RSC Adv. 2017 7 34994
• 3. Base controlled diverse reactivity of allyl cyanide for synthesis of multi-substituted benzenes
  Pratik Yadav,Ranjay Shaw,Amr Elagamy,Abhinav Kumar,Ramendra Pratap Org. Biomol. Chem. 2018 16 5465
• 4. Structure–activity relationships in Toll-like receptor 7 agonistic 1H-imidazo[4,5-c]pyridines
  Euna Yoo,Breanna M. Crall,Rajalakshmi Balakrishna,Subbalakshmi S. Malladi,Lauren M. Fox,Alec R. Hermanson,Sunil A. David Org. Biomol. Chem. 2013 11 6526
• 5. Pd-Catalyzed Suzuki coupling reactions of aryl halides containing basic nitrogen centers with arylboronic acids in water in the absence of added base
  Zhao Li,Carol Gelbaum,Zachary S. Campbell,Paul C. Gould,Jason S. Fisk,Bruce Holden,Arvind Jaganathan,Gregory T. Whiteker,Pamela Pollet,Charles L. Liotta New J. Chem. 2017 41 15420

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Chemical Profile of 4-Phenylbenzylamine (CAS No. 712-76-5)

4-Phenylbenzylamine, identified by the Chemical Abstracts Service Number (CAS No.) 712-76-5, is a significant organic compound belonging to the benzylamine class. This compound features a phenyl group attached to a benzylamine moiety, making it a valuable intermediate in synthetic chemistry and pharmaceutical research. Its molecular structure, characterized by a benzene ring substituted with an amino group and a phenylmethyl group, contributes to its versatility in various chemical transformations.

The synthesis of 4-Phenylbenzylamine typically involves the reaction of phenylacetonitrile with ammonia or ammonium hydroxide, followed by reduction using appropriate reducing agents such as lithium aluminum hydride (LiAlH?) or catalytic hydrogenation. Alternatively, nucleophilic substitution reactions on 4-bromobenzyl chloride can yield the desired product efficiently. The choice of synthetic route depends on factors such as yield, purity requirements, and scalability, which are critical in industrial and laboratory settings.

In recent years, 4-Phenylbenzylamine has garnered attention in the field of medicinal chemistry due to its potential applications as a building block for more complex pharmacophores. Its structural motif is reminiscent of several bioactive molecules, suggesting its utility in drug discovery programs. Specifically, derivatives of 4-Phenylbenzylamine have been explored as intermediates in the synthesis of central nervous system (CNS) therapeutics, where the amine group can be further functionalized to enhance binding affinity and selectivity.

One notable area of research involves the use of 4-Phenylbenzylamine in the development of novel antimicrobial agents. The phenyl ring provides a hydrophobic surface that can interact with bacterial cell membranes, while the amine group allows for hydrogen bonding interactions with target enzymes or receptors. Recent studies have demonstrated the efficacy of certain 4-Phenylbenzylamine derivatives against Gram-positive bacteria, highlighting their promise as lead compounds for future antibiotics.

Furthermore, the compound has found applications in materials science, particularly in the design of liquid crystals and organic semiconductors. The rigid aromatic backbone and electron-rich amine group contribute to favorable electronic properties, making 4-Phenylbenzylamine a suitable candidate for optoelectronic devices. Researchers have reported its incorporation into polymer matrices to enhance charge transport properties, which could be beneficial for flexible electronics and organic photovoltaics.

The spectroscopic and analytical characterization of 4-Phenylbenzylamine is another critical aspect of its study. Nuclear magnetic resonance (NMR) spectroscopy, particularly proton (1H) and carbon (13C) NMR, provides detailed insights into its molecular structure. Infrared (IR) spectroscopy aids in identifying functional groups such as the primary amine (–NH?) and aromatic C–H stretches. Mass spectrometry (MS) is employed for high-resolution molecular weight determination and structural elucidation.

Chromatographic techniques, including high-performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry (GC-MS), are essential for purifying and analyzing 4-Phenylbenzylamine samples. These methods ensure high purity levels required for pharmaceutical applications, where impurities can significantly impact efficacy and safety profiles. Additionally, computational chemistry approaches such as molecular modeling are increasingly used to predict binding interactions and optimize synthetic routes.

The toxicological profile of 4-Phenylbenzylamine is another important consideration in its application. While acute toxicity studies suggest moderate reactivity under standard conditions, chronic exposure risks require thorough evaluation. Researchers have conducted in vitro assays to assess potential genotoxicity and mutagenicity using models like Ames tests or mammalian cell lines. These studies help establish safe handling protocols and inform regulatory submissions.

In conclusion,4-Phenylbenzylamine (CAS No. 712-76-5) is a multifaceted compound with broad utility across pharmaceuticals, materials science, and synthetic chemistry. Its unique structural features make it a valuable precursor for developing novel therapeutics and advanced materials. As research continues to uncover new applications,4-Phenylbenzylamine will undoubtedly remain a cornerstone in scientific innovation.

• 709649-61-6(methyl(3-phenylphenyl)methylamine)
• 299915-80-3(Aminylium, [1,1'-biphenyl]-4-ylmethyl-)
• 177976-49-7(3-Phenylbenzylamine)
• 79825-74-4(Diphenyl-2,2',4,4',6,6'-d6-methylamine)
• 110931-72-1((4-Biphenylylmethyl)methylamine)
• 389602-69-1(AKOS BAR-2002)
• 389602-70-4([1,1'-Biphenyl]-4-methanamine, 4'-methyl-)
• 238428-24-5([1,1'-Biphenyl]-4-methanamine,hydrochloride (1:1))
• 1173246-91-7(4-(4-Methylphenyl)benzylamine Hydrochloride)
• 870837-46-0((3-Phenylphenyl)methanamine Hydrochloride)